GeoVax Labs, Inc. (GOVX)
1.47
+0.04
(+2.80%)
USD |
NASDAQ |
Mar 20, 16:00
1.42
-0.05
(-3.40%)
After-Hours: 20:00
GeoVax Labs Research and Development Expense (Quarterly) : 5.044M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| SIGA Technologies, Inc. | 5.041M |
| Rhythm Pharmaceuticals, Inc. | 42.03M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Savara, Inc. | 20.90M |